BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Drug Discovery

Taiwan FDA Has Accepted New Drug Application for Sacituzumab Govitecan

Everest Medicines Limited (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on developing and commercializing tra...

January 04, 2022 | News

SOPHiA GENETICS Hosts Symposium with GE Healthcare at RSNA 2021

Symposium encapsulates SOPHiA GENETICS and GE Healthcare alliance to provide joint solutions and multimodal analytics to healthcare providers and biopharma...

November 30, 2021 | News

Hetero and Shenzhen Beimei Pharmaceuticals launch antiviral drug Oselavir® in China

Hetero, a globally renowned vertically integrated pharmaceutical organization and Shenzhen Beimei Pharmaceuticals jointly announced that they have received...

November 12, 2021 | News

Merck and Ridgeback Announce Japanese Government to Purchase 1.6 Million Courses of Molnupiravir

Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced that the Japanese government will purch...

November 11, 2021 | News

Oncodesign and TiumBio Sign Collaboration Agreement for R&D of Fibrosis Drug Candidates

Oncodesign (ALONC – FR0011766229), a French biopharmaceutical company specialized in kinase inhibitor research and precision medicine, and TiumBio (K...

October 22, 2021 | News

Phillips-Medisize Increases Global Manufacturing Capacity

Medical and pharmaceutical solutions leader poised to scale manufacturing from new and expanded production facilities and R&D centers in Poland,&n...

October 20, 2021 | News

MSN Labs Launches Empagliflozin tablets at an affordable price for Diabetes Management in India

‘EMPAONE’ is intended to provide diabetes patients in need across India with an affordable and accessible therapeutic option. India being the d...

October 19, 2021 | News

Dr. Reddy's Laboratories Announces the Launch of Carmustine for Injection

The BiCNU® brand and generic market had U.S. sales of approximately $19.4 million MAT for the most recent twelve months ending in August 2021 a...

October 18, 2021 | News

Topelia Australia launches US$25M Series A call for COVID-19 ATT Ziverdox

Topelia Australia, a biotech company established to commercialise a novel ATT treatment for Australians in quarantine, has launched an investment pro...

October 14, 2021 | News

BD Launches Plunger Stopper in Partnership with Aptar Pharma to Enhance Biologic Drug Delivery

BD (Becton, Dickinson and Company) , a leading global medical technology company, today announced the launch of the BD SCF™ PremiumCoat&re...

October 13, 2021 | News

Luciole ,Cyclica to Accelerate Discovery of Novel Medicine

"Luciole aims to be the premier mitochondrial repair company by applying state-of-theart technology and an efficient, virtual company approach to developin...

October 07, 2021 | News

South Korea Advances Treatment of Polymyositis

Immunoforge (Co-CEOs Sung-min Ahn, Kiho Chang), a company specializing in developing new drugs for rare musculoskeletal diseases, has reported that th...

September 28, 2021 | News

Transcenta Received IND Clearance from NMPA of its Anti-sclerostin Monoclonal Antibody TST002

Currently there are over 100 million of people with various degree of osteoporosis and 4 million people in China with severe osteoporos...

September 27, 2021 | News

Mirum. Takeda to Develop and Commercialize Maralixibat for Rare Pediatric Liver Diseases in Japan

Partnership leverages Takeda’s leadership in rare disease, gastroenterology, and hepatology to advance maralixibat in a major market Mirum P...

September 23, 2021 | News

Stay Connected